Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
28
SPXX Quote, Financials, Valuation and Earnings
Last price:
$17.11
Seasonality move
:
-1.51%
Day range:
$16.89 - $17.23
52-week range:
$14.72 - $18.00
Dividend yield:
0.68%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
31K
Avg. volume:
29.8K
1-year change:
15.78%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Earnings Data
Next earnings date for SPXX
--
Most recent earnings per share
--
Missed by --
(Dec 23/2024)
Consensus Estimate
--
(Dec 23/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SPXX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|
Nuveen S&P 500 Dynamic Overwrite Fund Earnings Questions
-
How Much did Nuveen S&P 500 Dynamic Overwrite Fund Generate in Revenue Last Quarter?
Nuveen S&P 500 Dynamic Overwrite Fund reported -- worth of top line sales in its most recent quarter.
-
Did Nuveen S&P 500 Dynamic Overwrite Fund Beat Earnings Last Quarter?
Nuveen S&P 500 Dynamic Overwrite Fund announced earnings per share of -- which represents a miss of analyst forecast a -- per share.
-
Is Nuveen S&P 500 Dynamic Overwrite Fund Profitable?
Nuveen S&P 500 Dynamic Overwrite Fund reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Nuveen S&P 500 Dynamic Overwrite Fund EPS Next Year?
Nuveen S&P 500 Dynamic Overwrite Fund's earnings are forecast to grow from -- per share to -- per share next year representing an increase of --.
-
When is Nuveen S&P 500 Dynamic Overwrite Fund's Earnings Date?
Currently, Nuveen S&P 500 Dynamic Overwrite Fund has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on March 24, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is down 0.09% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 7.53% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 6.1% over the past day.
